Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group.

N Engl J Med. 2002 Jan 10;346(2):92-8.

PMID:
11784875
[PubMed - indexed for MEDLINE]
Free Article
2.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.

PMID:
12065068
[PubMed - indexed for MEDLINE]
Free Article
3.

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP.

Cancer. 2001 Dec 1;92(11):2902-10.

PMID:
11753965
[PubMed - indexed for MEDLINE]
4.

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.

Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Palamidas P, Vlachonikolis I; Greek Oncology Cooperative Group (GOCG) for Lung Cancer.

Lancet. 2001 May 12;357(9267):1478-84.

PMID:
11377599
[PubMed - indexed for MEDLINE]
5.

Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.

Rodriguez J, Cortes J, Calvo E, Azinovic I, Fernandez-Hildago O, Martinez-Monge R, Garzon C, de Irala J, Martinez-Aguillo M, Ramon Y Cajal T, Brugarolas A.

Cancer. 2000 Dec 15;89(12):2622-9.

PMID:
11135224
[PubMed - indexed for MEDLINE]
6.

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.

Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y.

Cancer Chemother Pharmacol. 2003 Jul;52(1):19-24. Epub 2003 Apr 24.

PMID:
12712259
[PubMed - indexed for MEDLINE]
7.

Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.

Langer C, Li S, Schiller J, Tester W, Rapoport BL, Johnson DH; Eastern Cooperative Oncology Group.

J Clin Oncol. 2007 Feb 1;25(4):418-23.

PMID:
17264337
[PubMed - indexed for MEDLINE]
8.

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G.

Anticancer Res. 2001 Jul-Aug;21(4B):3005-10.

PMID:
11712802
[PubMed - indexed for MEDLINE]
9.

Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer.

Stewart DJ, Tomiak E, Shamji FM, Maziak DE, MacLeod P.

Lung Cancer. 2004 May;44(2):241-9.

PMID:
15084389
[PubMed - indexed for MEDLINE]
10.

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.

Georgoulias V, Samonis G, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Grigoratou T, Palamidas P, Kouroussis C, Mavroudis D, Kakolyris S, Giannakakis T, Vlachonikolis J; Greek Cooperative Group for Lung Cancer.

Lung Cancer. 2001 Dec;34 Suppl 4:S47-51.

PMID:
11742702
[PubMed - indexed for MEDLINE]
11.

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

Smit EF, van Meerbeeck JP, Lianes P, Debruyne C, Legrand C, Schramel F, Smit H, Gaafar R, Biesma B, Manegold C, Neymark N, Giaccone G; European Organization for Research and Treatment of Cancer Lung Cancer Group.

J Clin Oncol. 2003 Nov 1;21(21):3909-17.

PMID:
14581415
[PubMed - indexed for MEDLINE]
12.

Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group.

Frasci G, Panza N, Comella P, Nicolella GP, Natale M, Manzione L, Bilancia D, Cioffi R, Maiorino L, De Cataldis G, Belli M, Micillo E, Mascia V, Massidda B, Lorusso V, De Lena M, Carpagnano F, Contu A, Pusceddu G, Comella G.

J Clin Oncol. 1999 Aug;17(8):2316-25.

PMID:
10561293
[PubMed - indexed for MEDLINE]
13.

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .

Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH.

Cancer. 2001 Nov 15;92(10):2639-47.

PMID:
11745199
[PubMed - indexed for MEDLINE]
14.

A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).

Schallier D, Neyns B, Fontaine C, Steene JV, De Mey J, Meysman M, De Grève J.

Lung Cancer. 2007 May;56(2):247-54. Epub 2007 Mar 6.

PMID:
17337086
[PubMed - indexed for MEDLINE]
15.

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.

Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Belani CP.

J Clin Oncol. 2003 Aug 15;21(16):3016-24. Epub 2003 Jul 1.

PMID:
12837811
[PubMed - indexed for MEDLINE]
16.

Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Gray JR, Morrissey LH, Kalman LA, Hon JK, Greco FA.

J Clin Oncol. 2002 Jul 1;20(13):2937-42.

PMID:
12089222
[PubMed - indexed for MEDLINE]
17.

Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594.

Hoang T, Dahlberg SE, Schiller JH, Johnson DH.

Lung Cancer. 2013 Jul;81(1):47-52. doi: 10.1016/j.lungcan.2013.03.018. Epub 2013 Apr 21.

PMID:
23611404
[PubMed - indexed for MEDLINE]
18.

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M.

Ann Oncol. 2007 Feb;18(2):317-23. Epub 2006 Nov 1.

PMID:
17079694
[PubMed - indexed for MEDLINE]
Free Article
19.

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.

Greco FA, Gray JR Jr, Thompson DS, Burris HA 3rd, Erland JB, Barton JH Jr, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD.

Cancer. 2002 Sep 15;95(6):1279-85.

PMID:
12216096
[PubMed - indexed for MEDLINE]
Free Article
20.

Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.

Zalcberg J, Millward M, Bishop J, McKeage M, Zimet A, Toner G, Friedlander M, Barter C, Rischin D, Loret C, James R, Bougan N, Berille J.

J Clin Oncol. 1998 May;16(5):1948-53.

PMID:
9586914
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk